Mifamurtide: A Review of its Use in the Treatment of Osteosarcoma

Mifamurtide (liposomal muramyl tripeptide phosphatidyl ethanolamine; Mepact®) is an immunomodulator with antitumor effects that appear to be mediated via activation of monocytes and macrophages. In the EU, mifamurtide is indicated in children, adolescents, and young adults for the treatment of high-...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Paediatric drugs 2010-06, Vol.12 (3), p.141-153
1. Verfasser:	Frampton, James E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adis Drug Evaluation Antimitotic agents Antineoplastic agents Dosage and administration Drug therapy Internal Medicine Medicine Medicine & Public Health Osteosarcoma Pediatrics Pharmacokinetics Pharmacotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!